CHM vs RAD

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CHM

CHIMERIC FPO [CHM]

32LOW

RAD

RADIOPHARM FPO [RAD]

36LOW

Score Breakdown

CHM RAD
Technical
58
27
Catalyst
55
51
Sentiment
50
50
Fundamental
6
76
Momentum
39
52
Risk Gate
27
27

Key Metrics

CHM Metric RAD
$8.8MMarket Cap$42.6M
8.4MAvg Volume (20d)4.2M
N/AShort Interest+0.1%
$0.00952-Week High$0.040
$0.00152-Week Low$0.017
+0.0%Daily Change-5.3%
$0.002Entry Price$0.018
-1291.0%ROE-92.1%
-192.7%Profit Margin-286.2%

Active Signals

CHM Signals

Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.2 quarters)
Low P/S ratio (0.9x)
Revenue in sharp decline (-53%)
Piotroski F-Score weak (3/9, low-confidence approx)
EPS estimates revised downward (-10pts)

RAD Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
Trading below both moving averages — the trend is working against this one
Volume surging at 2.6x normal while price falls — heavy selling pressure
Broke below 20-day support — that's a level the market was defending, and it just gave way
Took a hit — down 18.2% over the last 5 days

Ask Scout AI to compare CHM and RAD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CHM Full Analysis → RAD Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).